Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Carcinoma of the Lungs”

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 0 results

Early research (Phase 1)Active Not RecruitingNCT06544655
What this trial is testing

BMS-986484 Alone and Combination Therapy in Participants With Advanced Solid Tumors

Who this might be right for
Advanced Solid Tumors
Bristol-Myers Squibb 213
Post-approval studies (Phase 4)Not Yet RecruitingNCT07567313
What this trial is testing

Stage IV Lung Squamous Cell Carcinoma Treated With or Without Bronchial Artery Chemoembolization After First-line Chemotherapy and Immunotherapy

Who this might be right for
Lung Squamous Cell Carcinoma Stage IV
Union Hospital, Tongji Medical College, Huazhong University of Science and Technology 166
Testing effectiveness (Phase 2)Not Yet RecruitingNCT06306560
What this trial is testing

Adebrelimab Combined With Famitinib and Chemotherapy in the Treatment of ES-SCLC.

Who this might be right for
Extensive-stage Small-cell Lung Cancer
Harbin Medical University 40
Testing effectiveness (Phase 2)Study completedNCT00252382
What this trial is testing

Safety and Efficacy Clinical Study of SNS-595 for Second-Line Therapy in Patients With Advanced NSCLC

Who this might be right for
Carcinoma, Non-Small-Cell Lung
Sunesis Pharmaceuticals 31
Early research (Phase 1)Looking for participantsNCT07046923
What this trial is testing

LY4175408 in Participants With Advanced Cancer

Who this might be right for
Carcinoma, Non-Small-Cell LungSmall Cell Lung CarcinomaEndometrial Neoplasms+2 more
Eli Lilly and Company 240
Testing effectiveness (Phase 2)UnknownNCT02974933
What this trial is testing

Apatinib Mesylate Combined With Pemetrexed in the Treatment of Pretreated Advanced Non-squamous Non-small Cell Lung Cancer

Who this might be right for
Nonsmall Cell Lung Cancer
Wuling Ou 48
Testing effectiveness (Phase 2)Active Not RecruitingNCT05526755
What this trial is testing

5 Years of Adjuvant Osimertinib in Completely Resected Epidermal Growth Factor Receptor Mutation (EGFRm) Non-small Cell Lung Carcinoma (NSCLC)

Who this might be right for
Stage II-IIIB Non-small Cell Lung Carcinoma
AstraZeneca 188
Not applicableNot Yet RecruitingNCT07273279
What this trial is testing

ADH1B and ALDH Gene Variants and Lung Cancer Risk

Who this might be right for
Condition/DiseaseLung Cancer (Diagnosis)Lung Adenocarcinoma
Kaohsiung Medical University 100,000
Not applicableLooking for participantsNCT07510724
What this trial is testing

Real-World Data on the Treatment of Lung Cancer Patients With the Immune-Checkpoint Inhibitor Tislelizumab

Who this might be right for
Small Cell Lung Cancer (SCLC)Non-Small Cell Lung Cancer (NSCLC)Lung Cancer (Diagnosis)
Institut für Klinische Krebsforschung IKF GmbH at Krankenhaus Nordwest 240
Testing effectiveness (Phase 2)Study completedNCT01362296
What this trial is testing

An Open-label Study of GSK1120212 Compared With Docetaxel in Stage IV KRAS-mutant Non-small Cell Lung Cancer

Who this might be right for
Lung Cancer, Non-Small Cell
GlaxoSmithKline 134
Testing effectiveness (Phase 2)Looking for participantsNCT04787042
What this trial is testing

Phase 1a and Phase 2 Study for Safety, Preliminary Efficacy, PK and PD of ST-067

Who this might be right for
CancerSolid TumorMelanoma+6 more
Simcha IL-18, Inc. 316
Early research (Phase 1)Study completedNCT01352962
What this trial is testing

Gemcitabine, Carboplatin, and Lenalidomide for Treatment of Advanced/Metastatic Urothelial Cancer and Other Solid Tumors

Who this might be right for
Urethral NeoplasmsNeoplasms, UrethralCancer of the Urethra+1 more
National Cancer Institute (NCI) 18
Testing effectiveness (Phase 2)UnknownNCT00561054
What this trial is testing

Efficacy and Safety of Cetuximab in Combination With Cisplatin Gemcitabine as First-Line Therapy in Advanced NSCLC

Who this might be right for
Carcinoma, Non-Small-Cell Lung
Grupo Portugues de Estudo do Cancro do Pulmao 47
Testing effectiveness (Phase 2)Study completedNCT00454194
What this trial is testing

Pemetrexed Disodium With or Without Sorafenib as Second-Line Therapy in Treating Patients With Stage IIIB or Stage IV Non-Small Cell Lung Cancer

Who this might be right for
Lung Cancer
Alliance for Clinical Trials in Oncology 110
Not applicableUnknownNCT02934360
What this trial is testing

TR(ACE) Assay Clinical Specimen Study

Who this might be right for
Carcinoma, Non-Small-Cell LungBreast Neoplasms
Biological Dynamics 450
Testing effectiveness (Phase 2)Ended earlyNCT02192697
What this trial is testing

An Open Study of ASP8273 in Patients With Non-Small-Cell Lung Cancer (NSCLC) Who Have Epidermal Growth Factor Receptor (EGFR) Mutations

Who this might be right for
Non-small Cell Lung Cancer
Astellas Pharma Inc 124
Post-approval studies (Phase 4)Study completedNCT01230710
What this trial is testing

Tarceva (Erlotinib) in Patients With Locally Advanced or Metastatic Non-small Cell Lung Cancer Following 4 Cycles of Platinum-based Chemotherapy Without Disease Progression

Who this might be right for
Non-Small Cell Lung Cancer
Hoffmann-La Roche 51
Early research (Phase 1)Active Not RecruitingNCT06253520
What this trial is testing

Autologous T-cells Genetically Engineered to Express Receptors Reactive Against KRAS Mutations in Conjunction With a Vaccine Directed Against These Antigens in Participants With Metastatic Cancer

Who this might be right for
Metastatic Solid CancersColorectal CancerBreast Cancer+4 more
National Cancer Institute (NCI) 210
Testing effectiveness (Phase 2)Ended earlyNCT00234442
What this trial is testing

Iressa in the Treatment of Brain Metastases From Non Small Cell Lung Cancer

Who this might be right for
Brain NeoplasmsNon Small Cell Lung Cancer
AstraZeneca 47
Not applicableStudy completedNCT01190527
What this trial is testing

Using FDG-PET During Radiation Therapy in Non-Small Cell Lung Cancer

Who this might be right for
Non-Small Cell Lung Cancer
University of Michigan Rogel Cancer Center 42
Next Page